Azịza ngwa ngwa
UCB's October 2026 FDA approval of a ZILBRYSQ autoinjector adds a second self-administration option alongside the existing prefilled syringe, with commercial a…
Kedu ihe FDA kwadoro maka ZILBRYSQ, na ihe akaebe kwadoro autoinjector?
Ozi Peptide Hexarelin Peptide Nkwenye ahụ dabere na ụdị ọmụmụ ihe atọ, na onye ọ bụla na-aza ajụjụ dị iche. Data ojiji nke oge 3b dị na ọkwa ọkwa UCB na-ekwupụta nnyefe dose zuru oke maka 99.8% (n=449) nke nchịkwa autoinjector, ebe denominator bụ mkpokọta autoinjectors ejiri wee laghachi, ọ bụghị ndị ọrịa (Ọkwa nkwado nke UCB).
Ihe ọmụmụ nkwado ihe mmadụ debanyere aha 100 sonyere n'ofe ndị ọrịa, ndị nlekọta na ndị ọkachamara nlekọta ahụike, na 90% dechara ogwu ogbugba na mgbalị mbụ na-enweghị ọzụzụ (Ọkwa nkwado nke UCB). Ọmụmụ bioequivalence kọwara na ntọhapụ, DV0012, bụ crossover oge abụọ na 14 ndị okenye nwere ahụike; Ntọhapụ ahụ kwuru na emebere bioequivalence mana enweghị oke AUC ma ọ bụ Cmax.
Ihe na-abụghị ihe gbasara ọha: ihe mkpuchi akpa nke autoinjector, ya extractables na leachables ngwugwu, na data mmechi mmechi ya adịghị na ma ntọhapụ na akara.
Ntugharị igodo Ihe mgbakwunye ngwaọrụ na-agbakwunye nhọrọ nchịkwa na otu molekul na egosi. Mgbanwe nhazi na-agbanwe ngwaahịa ọgwụ n'onwe ya. Ha abụọ na-ebu ibu ihe àmà dị iche iche, na naanị nke abụọ na-emepekwa nkọwapụta ọgwụ ọgwụ.
Kedu ihe kpatara na usoro na nkọwapụta ịdị ọcha akwadobeghị nke ọma iji wepụta peptide ngwaọrụ ewepụtara?
Njikere nnyefe peptide bụ akụrụngwa nke ngwaahịa ọgwụ n'ime akpa na ngwaọrụ ya, ọ bụghị nke akwụkwọ ọgwụ ọgwụ. Nkọwapụta bụ njikwa dị warara site na imewe. I Q6B na-akọwa Peptide mmadụ ya dị ka ndepụta nke ule, usoro nyocha na njirisi nnabata nke onye nrụpụta tụpụtara. Ọ na-akwado ịdị mma; ọ naghị ewepụta njirimara zuru oke. USP <1503> na-enye peptides sịntetik otu udi: ọdịdị, njirimara site na usoro orthogonal, nyocha, adịghị ọcha na ụfọdụ ule.
Ọ dịghị nke ọ bụla n'ime ha na-akọwa otú molekul ahụ si akpa àgwà mgbe mmiri na-ebugharị ya n'ime agịga dị 29.. FDA nke Ụlọ ọrụ ngwaahịa Peptide 2026 ntụzịaka ntụzịaka mmechi-akpa-akpọ piston sirinji n'etiti sistemu mmechi nke bụkwa akụkụ ngwaọrụ. Ọ na-atụ anya ike glide, agbaji-loose ike na akara iguzosi ike n'ezi ule ule.
Ngwaahịa ahụ nwere ọtụtụ njupụta na ike. Nyochaa ngosipụta akwadoro na nhazi ngwaọrụ maka nke ọ bụla; mpịakọta dị iche iche anaghị egosi na otu ngwaọrụ nwere ike ijikwa ihe ngosi ọ bụla.
Ịgwọ ihe akaebe ngwaọrụ dị ka nhọrọ nwere ọnụ ahịa edepụtara. Akwụkwọ ozi nzaghachi FDA zuru oke maka Remodulin kwuo na "ihe zuru oke nke mmadụ (HF) E nyebeghị data iji gosipụta na… interface onye ọrụ na-akwado ojiji dị mma ma dịkwa mma.
Olee otú itinye uche, dose olu, viscosity na kọntaktị akpa kpebiri ma usoro ngwaọrụ ọ ga-ekwe omume?
Ịrụ ọrụ ngwaọrụ dabere na olu, viscosity, geometry agịga, ike, okpomọkụ na nhazi ọnụ. Ihe atụ na-eji agịga dị iche iche enweghị ike iwepụ mmetụta viscosity. Tọọ ihe achọrọ site na iji ọkọlọtọ ngwaọrụ dị na nhazi kama ịbụ olu zuru ụwa ọnụ ma ọ bụ 10 N oke. Peptides na-egbochi nje
<klas ọgụgụ ="blọọgụ-akara ngosi" ụdị ="oke-obosara:640px;oke:1.5rem akpaaka;font-nha:12px;ahịrị-ịdị elu:1.3;agba:eketa"> <svg viewBox="0 0 560 380" ụdị ="oke-obosara: 100%; elu: akpaaka; font-ezinụlọ: 'Inter', usoro-ui, sans-serif; agba: #1e293b; --chaatị-mechiri emechi: #64748b;" ọrụ ="img" aria-labeledby="zilbrysq-dose-olu-site-arọ-band-title zilbrysq-dose-olu-site-arọ-band-desc"> <ịke> /* Onye nrụpụta na-etinye eserese ahụ n'ime iframe nke ihe ndabere ya dị oji, na iframe bụ ọdịdị dị iche na chaatị ahụ, ya mere eriri igbe akwụkwọ ozi gosipụtara dị ka okpokolo agba gbara ya gburugburu (prod 09-22). Akwụkwọ dị n'ime iframe pụtara ìhè na ndabara; esere ya ebe a na-ekpuchi ndabere elementrị, na mgbe e debere chaatị ahụ kama nke a dabara na ihe ọ bụla. Debe brackets n'akuku na ngọngọ a: A na-atụgharị akụkụ ụdị n'ime SVG dị ka ọdịnaya nke mba ọzọ, ya mere otu nkwado kpafuru akpafu na-atụfu iwu niile dị na ya. */ html, ahu { ndabere: #fffff; oke: 0; } @mgbasa ozi (na-ahọrọ-ebelata-mmegharị: belata) { * { animation: onweghi !mkpa; mgbanwe: onweghi !mkpa; } } </ịke> <ziri ezi x="0" y="0" obosara ="560" elu ="380" rx="8" juru ="#fffff" /> <aha id="zilbrysq-dose-olu-site-arọ-band-aha">Olu nke ZILBRYSQ site na eriri arọ</aha> <desc id ="zilbrysq-dose-olu-site-arọ-band-desc">Ike atọ akwadoro na-ebuga 0.416, 0.574 na 0.81 mL kwa otu ugboro kwa ụbọchị nke subcutaneous dose. Olu nke ZILBRYSQ site na eriri arọ. data mgbochi kwụ ọtọ: <56 n'arọ 0.416; 56 ka <77 n'arọ 0.574; ≥77 n'arọ 0.81.Iyi: ZILBRYSQ ozi ndenye 2023.</desc> <ederede x ="280.0" y="29" ederede-arịlịka ="etiti" font-size ="18" font-arọ="800" juru ="Agba ugbu a">Olu nke ZILBRYSQ site na eriri arọ</ederede> <ahịrị x1="145" y1="298.0" x2="510" y2="298.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="243.0" x2="510" y2="243.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="188.0" x2="510" y2="188.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="133.0" x2="510" y2="133.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="78.0" x2="510" y2="78.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ederede x ="136.0" y="122.2" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0"><56 n'arọ</tsp></ederede> <ziri ezi x="145" y="78.0" obosara ="151.8" elu ="68.0" rx="4" juru ="#f97316" /> <ederede x ="304.8" y="122.2" font-size ="11" juru ="Agba ugbu a">0.416</ederede> <ederede x ="136.0" y="198.2" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">56 ka <77 n'arọ</tsp></ederede> <ziri ezi x="145" y="154.0" obosara ="209.5" elu ="68.0" rx="4" juru ="#38bdf8" /> <ederede x ="362.5" y="198.2" font-size ="11" juru ="Agba ugbu a">0.574</ederede> <ederede x ="136.0" y="274.2" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">≥77 n'arọ</tsp></ederede> <ziri ezi x="145" y="230.0" obosara ="295.7" elu ="68.0" rx="4" juru ="#nke 78bfa" /> <ederede x ="448.7" y="274.2" font-size ="11" juru ="Agba ugbu a">0.81</ederede> <ederede x ="280.0" y="366" ederede-arịlịka ="etiti" font-size ="10" juru ="anyi(--chaatị-mechiri emechi, Agba ugbu a)">Isi mmalite: ZILBRYSQ ozi na-edepụta (2023)</ederede> </svg> </ọgụgụ>
Kọntaktị akpa bụ ebe akwụkwọ peptide na-akwụsị. Na epoetin alfa prefilled-syringe case, Batches abụọ jupụtara site na otu ngwọta dị iche iche naanị na njupụta, na sirinji onye ọ bụla gbakọtara ruo 5.1% na 1.5%, na soluble tungsten nkezi banyere 1 ppm na iru 4 ppm na sirinji onye ọ bụla (Seidl et al. na nyocha ọgwụ). Data ihu mmiri tungsten ebipụtara na-egosi ọnụ ụzọ na-esi n'ihe dị ka 3 pH na pH 5.0 ka ọ dịghị mmiri ozuzo n'elu 200 pH na pH 6.0 (Bee et al. na Journal of Pharmaceutical Sciences). Mmanụ silicone na tungsten bụ akpa mpụta, ọ bụghị peptide àgwà, yabụ enweghị ike ịkwado ndakọrịta mmechi akpa peptide site na ndị na-ebubata ihe.
Ihe ndị a na-amịpụta na ihe ndị nwere ike ịpụ apụ nwere usoro na ọnụ ụzọ nke ha. USP <1663> na <1664> tọọ usoro ntule, mgbe PQRI parenteral E&L ebe a 1.5 µg/ụbochị nchekwa nchekwa ụbọchị yana a 5 µg/ụbọchị iru eru maka organic leachable n'otu n'otu (USP; PQRI). Usoro ntuziaka ICH Q3E, na Nzọụkwụ 2 kemgbe August 2025, gbatịa oke na ngwaahịa ngwakọta ngwaọrụ ọgwụ yana mmejuputa a na-atụ anya ya na June 2027 (Nzọụkwụ Q3E 2 ngosi).
Kedu ihe m ga-achọ n'aka onye mmekọ peptide m na onye otu ngwaọrụ m tupu ịgbachichi usoro?
Kpọchie usoro ngwaọrụ naanị mgbe ngwugwu ọgwụ gachara, enyochala njirimara nhazi na profaịlụ nke akpa ahụ nwere ike wepụ ọnụ. Nke ahụ na-eme njikere nnyefe peptide bụ mkpebi nkwonkwo, ọ bụghị a handoff.
<klas ọgụgụ ="blọọgụ-akara ngosi" ụdị ="oke-obosara:640px;oke:1.5rem akpaaka;font-nha:12px;ahịrị-ịdị elu:1.3;agba:eketa"> <svg viewBox="0 0 560 380" ụdị ="oke-obosara: 100%; elu: akpaaka; font-ezinụlọ: 'Inter', usoro-ui, sans-serif; agba: #1e293b; --chaatị-mechiri emechi: #64748b;" ọrụ ="img" aria-labeledby="nne na nna-leachable-thresholds-aha parenteral-leachable-thresholds-desc"> <ịke> /* Onye nrụpụta na-etinye eserese ahụ n'ime iframe nke ihe ndabere ya dị oji, na iframe bụ ọdịdị dị iche na chaatị ahụ, ya mere eriri igbe akwụkwọ ozi gosipụtara dị ka okpokolo agba gbara ya gburugburu (prod 09-22). Akwụkwọ dị n'ime iframe pụtara ìhè na ndabara; esere ya ebe a na-ekpuchi ndabere elementrị, na mgbe e debere chaatị ahụ kama nke a dabara na ihe ọ bụla. Debe brackets n'akuku na ngọngọ a: A na-atụgharị akụkụ ụdị n'ime SVG dị ka ọdịnaya nke mba ọzọ, ya mere otu nkwado kpafuru akpafu na-atụfu iwu niile dị na ya. */ html, ahu { ndabere: #fffff; oke: 0; } @mgbasa ozi (na-ahọrọ-ebelata-mmegharị: belata) { * { animation: onweghi !mkpa; mgbanwe: onweghi !mkpa; } } </ịke> <ziri ezi x="0" y="0" obosara ="560" elu ="380" rx="8" juru ="#fffff" /> <aha id="parenteral-leachable-thresholds-aha">Ọnụ ụzọ nwere ike ime ka nne na nna</aha> <desc id ="parenteral-leachable-thresholds-desc">PQRI na-ahazi a 1.5 µg/ụbochị nchekwa nchekwa ụbọchị yana a 5 µg/ụbọchị iru eru maka organic leachable. Ọnụ ụzọ nwere ike ime ka nne na nna. data lollipop: Nchegbu nchekwa 1.5; Ikike 5.Isi iyi: PQRI PODP Leachables & Otu na-arụ ọrụ Extractables 2021-10-28.</desc> <ederede x ="280.0" y="29" ederede-arịlịka ="etiti" font-size ="18" font-arọ="800" juru ="Agba ugbu a">Ọnụ ụzọ nwere ike ime ka nne na nna</ederede> <ahịrị x1="145" y1="298.0" x2="510" y2="298.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="243.0" x2="510" y2="243.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="188.0" x2="510" y2="188.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="133.0" x2="510" y2="133.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ahịrị x1="145" y1="78.0" x2="510" y2="78.0" ọrịa strok ="Agba ugbu a" opacity="0.08" /> <ederede x ="136.0" y="137.0" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Nchegbu nchekwa</tsp></ederede> <ahịrị x1="145" y1="133.0" x2="254.5" y2="133.0" ọrịa strok ="Agba ugbu a" opacity="0.15" obosara-strok="1" /> <okirikiri cx="254.5" cy="133.0" r="6" juru ="#f97316" /> <ederede x ="266.5" y="137.0" font-size ="11" juru ="Agba ugbu a">1.5</ederede> <ederede x ="136.0" y="247.0" ederede-arịlịka ="ngwucha" font-size ="11" juru ="Agba ugbu a" opacity="0.8"><otu x ="136.0" dy="0">Ikike</tsp></ederede> <ahịrị x1="145" y1="243.0" x2="510.0" y2="243.0" ọrịa strok ="Agba ugbu a" opacity="0.15" obosara-strok="1" /> <okirikiri cx="510.0" cy="243.0" r="6" juru ="#38bdf8" /> <ederede x ="522.0" y="247.0" font-size ="11" juru ="Agba ugbu a">5</ederede> <ederede x ="280.0" y="366" ederede-arịlịka ="etiti" font-size ="10" juru ="anyi(--chaatị-mechiri emechi, Agba ugbu a)">Isi mmalite: PQRI PODP Leachables & Ndị na-arụ ọrụ Extractables (2021-10-28)</ederede> </svg> </ọgụgụ>
Rịọ njirimara, ịdị ọcha, ọdịnaya na ihe akaebe kwụsiri ike dị mkpa maka peptide na ihe ngosi emechara. Họrọ nchekwa na ọnọdụ ngwa ngwa site na nhazi ahụ, nkwuputa nchekwa echere na ntụzịaka dị; friji Q1A(R2) Ọnọdụ abụghị nkọwa zuru ụwa ọnụ maka ngwaahịa ngwaọrụ-peptide niile.
Site na onye mmekọ ngwaọrụ, Rịọ injection-ike na nyocha nke ziri ezi megide ISO 11608-1, nke na-ekpuchi sistemu agịga na-eme otu ihe na-agụnye sirinji emejuru (ISO 11608-1:2022), ngwugwu nke extractables na leachables, nsonaazụ mmechi mmechi akpa, na autoinjector ihe mmadụ na-anwale na ndị ọrụ nnọchiteanya na njedebe ikpeazụ. FDA nke 2016 nduzi ihe gbasara mmadụ na-eleba anya n'ihe ọmụmụ ihe mmadụ maka ngwaahịa ngwakọta, na-akọwa ụdị ọmụmụ ihe na ndụmọdụ maka oge ha (Ntuziaka ihe gbasara mmadụ FDA).
Ejila bioequivalence naanị dị ka njikere ngwaọrụ, agbachila ikpo okwu tupu edee ntule ihe ize ndụ nke imechi akpa, ma agụkwala akwụkwọ ntuziaka dịka ihe achọrọ. Omume ụlọ ọrụ kọrọ anyị, edeghị ya na ntuziaka, na-esetịpụ atụmatụ ngwaọrụ site na tupu IND ma ọ bụ mmalite oge 2 na ikpo okwu-ebumnobi azụmahịa na njedebe nke Usoro 2.
Jụọ onye ibe gị peptide maka ngwungwu data ọkwa nza tupu ị kpọchie usoro ngwaọrụ. Onye nrụpụta Polypeptid
Otu anyị si etinye nke a na MOL Changes, onye bipụtara akwụkwọ ntuziaka a. Ngwakọta peptide omenala anyị na-enye ihe nwere ọtụtụ ihe na ịdị ọcha ekwuputara, site mg ruo n'arọ, na HPLC na MS ule, nke na-ekpuchi njirimara na data ịdị ọcha nke ị rịọrọ n'aka onye mmekọ peptide. Ọ naghị ewepụta arụmọrụ ngwaọrụ, nkwụsi ike na akpa, ma ọ bụ nnabata iwu; ndị ị ka na-enyocha ya na onye mmekọ ngwaọrụ gị yana ọmụmụ nke gị.
Ajụjụ a na-ajụkarị
Nkwenye nke ZILBRYSQ autoinjector pụtara peptide m chọrọ autoinjector?
Mba. Nkwenye ahụ na-agbakwụnye nhọrọ nchịkwa n'akụkụ sirinji emejuru nke dị maka otu ngwaahịa n'otu ihe ngosi (Ọkwa nkwado nke UCB). Ma mmemme gị chọrọ ngwaọrụ dabere na oke dose, viscosity na ọnụ ọgụgụ ndị ọrụ, ọ bụghị na ntinye akwụkwọ nke ndị asọmpi.
Bụ akwụkwọ nyocha nke zuru oke iji kwado ntinye ngwaọrụ?
Ọ na-akwado naanị akụkụ nke ọgwụ. Nkọwapụta n'okpuru ICH Q6B na-akwado ịdịmma yana anaghị akọwapụta arụmọrụ nnyefe, na akụkụ ndị mejupụtara ngwaọrụ na-ebu atụmanya dị iche iche maka ike glide, agbaji-atọ ike na akara iguzosi ike n'ezi ihe (I Q6B).
Ogologo oge ka ngwaọrụ kwesịrị ịmalite n'ihe gbasara mkpọchi nhazi?
Isi mmalite anaghị ewepụta ọkọlọtọ oge edekọtara. Ihe ha na-egosi bụ na kọntaktị akpa nwere ike ịgbanwe àgwà ngwaahịa na nhazi nhazi, dị ka ntụnyere njupụta nke epoetin alfa gosiri, ya mere ntule ihe ize ndụ nke imechi akpa bụ tupu edozi usoro karịa ka emechara (Seidl et al.).
ICH Q3E ọ na-emetụta ngwaahịa nchikota m taa?
Chọpụta ụkpụrụ nduzi na ihe ndị a chọrọ. Lelee ICH Q3E dị ugbu a yana ọkwa mmejuputa mpaghara mgbe ị na-edozi atụmatụ extractables-na-leachables; ụbọchị mmejuputa amụma abụghị njedebe na-adịgide adịgide.
Mmechi
A na-agụ nkwenye ZILBRYSQ dị ka ngosipụta nke ebe ihe akaebe dị n'ezie. Mkpụrụ ndụ ahụ agbanweghị; akpa ahụ, interface ngwaọrụ na interface onye ọrụ mere, na ngwugwu nkwado bụ bioequivalence, usability na data ihe ndị mmadụ karịa nkọwapụta ịdị ọcha ọhụrụ.
Nke ahụ na-egosipụta ihe onye mmekọ peptide ji gị. Lot-kpọmkwem njirimara na ịdị ọcha, ngwugwu kwụsie ike n'okpuru ICH Q1A(R2), na nkwupụta doro anya nke pH na usoro nchekwa bụ ihe onye mmekọ njikọ nwere ike ịnye na onye mmekọ ngwaọrụ enweghị ike. Nsonaazụ mwepu na nke enwere ike ịpụ, iguzosi ike n'ezi ihe mmechi akpa, nha ike na nkwado ihe mmadụ bụ nke akụkụ ngwaọrụ, na enweghị peptide akwụkwọ dochie ha.
Nzọụkwụ ọzọ bara uru bụ ịdepụta ngwungwu data gị ugbu a megide nkewa ahụ tupu mkparịta ụka usoro ọ bụla amalite. Ebe akụkụ peptide zuru ezu na akụkụ ngwaọrụ adịghị, ị maara mkparịta ụka nke ọzọ ị ga-enwe, ya na onye.
Nkpughe nke onye mbipụta: MOL Mgbanwe na-enye ọrụ peptide ma nwee mmasị azụmahịa na isiokwu a. Ogo ọrụ na nkwupụta ikike bụ nkwupụta ndị na-ebubata ya; nnweta na ịrụ ọrụ maka otu ihe owuwu chọrọ ihe akaebe akọwapụtara nke ọma.
